Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.38B |
| 2 |
Microsoft
MSFT
|
+$2.02B |
| 3 |
Apple
AAPL
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$861M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.67B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.49B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$867M |
| 4 |
Tesla
TSLA
|
+$550M |
| 5 |
GE Aerospace
GE
|
+$483M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Financials | 6.62% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.85% |
| 5 | Communication Services | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGAU
4101
Centerra Gold
CGAU
$3.27B
| $115K | ﹤0.01% |
6,488
-44,398
| -87% | -$789K |
|
|
KE
4102
Kimball Electronics
KE
$598M
| $114K | ﹤0.01% |
4,828
-11,544
| -71% | -$305K |
|
4103
Global Industrial
GIC
$1.36B
| $114K | ﹤0.01% |
3,612
+1,758
| +95% | +$55.3K |
|
|
CDNL
4104
Cardinal Infrastructure Group
CDNL
$1.26B
| $113K | ﹤0.01% |
+2,855
| New | +$82.7K |
|
|
PRSU
4105
Pursuit Attractions and Hospitality Inc
PRSU
$1.46B
| $113K | ﹤0.01% |
3,088
-11,038
| -78% | -$394K |
|
4106
C4 Therapeutics
CCCC
$397M
| $112K | ﹤0.01% |
42,428
-7,412
| -15% | -$17.5K |
|
4107
United States Antimony
UAMY
$808M
| $111K | ﹤0.01% |
12,742
+10,049
| +373% | +$87.6K |
|
4108
iShares US Healthcare ETF
IYH
$3.38B
| $111K | ﹤0.01% |
1,804
+1,801
| +60,033% | +$116K |
|
4109
Triple Flag Precious Metals
TFPM
$6B
| $110K | ﹤0.01% |
3,191
+3,184
| +45,486% | +$115K |
|
4110
Rayonier Advanced Materials
RYAM
$573M
| $109K | ﹤0.01% |
9,887
+3,549
| +56% | +$32K |
|
|
GOOS
4111
Canada Goose Holdings
GOOS
$891M
| $109K | ﹤0.01% |
9,984
+9,619
| +2,635% | +$116K |
|
|
AMBQ
4112
Ambiq Micro
AMBQ
$1.65B
| $109K | ﹤0.01% |
4,294
+3,193
| +290% | +$95.2K |
|
4113
MiMedx Group
MDXG
$635M
| $109K | ﹤0.01% |
27,545
+14,407
| +110% | +$72.6K |
|
|
LABX
4114
Tradr 2X Long ALAB Daily ETF
LABX
$8.33M
| $109K | ﹤0.01% |
+43,692
| New | +$225K |
|
|
TSMX
4115
Direxion Daily TSM Bull 2X ETF
TSMX
$620M
| $109K | ﹤0.01% |
1,900
-31,000
| -94% | -$1.91M |
|
4116
Orchestra BioMed
OBIO
$229M
| $108K | ﹤0.01% |
25,529
+6,071
| +31% | +$25.8K |
|
4117
SELLAS Life Sciences
SLS
$2.13B
| $108K | ﹤0.01% |
25,646
-29,829
| -54% | -$133K |
|
4118
Emergent Biosolutions
EBS
$378M
| $108K | ﹤0.01% |
13,049
+1,808
| +16% | +$18.7K |
|
4119
Preformed Line Products
PLPC
$1.52B
| $108K | ﹤0.01% |
400
-338
| -46% | -$86.4K |
|
4120
Caribou Biosciences
CRBU
$158M
| $108K | ﹤0.01% |
56,923
-17,648
| -24% | -$30.3K |
|
4121
Relmada Therapeutics
RLMD
$546M
| $107K | ﹤0.01% |
15,414
-7,120
| -32% | -$33.7K |
|
4122
FreightCar America
RAIL
$279M
| $107K | ﹤0.01% |
13,448
-9,245
| -41% | -$105K |
|
4123
Community Health Systems
CYH
$383M
| $107K | ﹤0.01% |
36,418
+30,975
| +569% | +$100K |
|
|
JBIO
4124
Jade Biosciences
JBIO
$1.21B
| $107K | ﹤0.01% |
7,616
+6,281
| +470% | +$90.9K |
|
4125
Cannae Holdings
CNNE
$650M
| $107K | ﹤0.01% |
9,400
-12,141
| -56% | -$163K |
|
Similar funds
Citigroup's Q1 2026 Portfolio in Review
As of Q1 2026, Citigroup held 6,546 positions worth $235B, up 3.5% from $227B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citigroup deployed $16.9B of net new capital in Q1 2026, opening 553 new positions and adding to 2,742 existing holdings. Its largest new stake was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.67B trimmed.
- Citigroup's largest Q1 2026 buy was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
- Citigroup added most to NVIDIA in Q1 2026, an estimated $2.38B increase.
- Citigroup's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.67B.
- Citigroup fully exited CyberArk in Q1 2026, selling an estimated $241M.
- Citigroup's ten largest holdings make up 19% of its $235B portfolio in Q1 2026.
- Citigroup opened 553 new positions and closed 630 in Q1 2026.
- Citigroup's portfolio value rose 3.5% quarter-over-quarter to $235B.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.